SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-038015
Filing Date
2024-03-28
Accepted
2024-03-28 16:04:44
Documents
13
Period of Report
2024-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scyx-20240328.htm   iXBRL 8-K 54874
2 EX-99.1 scyx-ex99_1.htm EX-99.1 212123
3 GRAPHIC img135655574_0.jpg GRAPHIC 3554
  Complete submission text file 0000950170-24-038015.txt   400581

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20240328.xsd EX-101.SCH 26192
16 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20240328_htm.xml XML 4696
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 24798764
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)